Who should receive hepatitis A vaccine? (English)
- New search for: Arankalle, V. A.
- New search for: Chadha, M. S.
- New search for: Arankalle, V. A.
- New search for: Chadha, M. S.
In:
JOURNAL OF VIRAL HEPATITIS
;
10
;
157-158
;
2003
-
ISSN:
- Article (Journal) / Print
-
Title:Who should receive hepatitis A vaccine?
-
Contributors:Arankalle, V. A. ( author ) / Chadha, M. S. ( author )
-
Published in:JOURNAL OF VIRAL HEPATITIS ; 10 ; 157-158
-
Publisher:
- New search for: BLACKWELL SCIENTIFIC PUBLICATIONS
-
Publication date:2003-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 10
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Hepatitis B vaccine – do we need boosters?Banatvala, J. E. / Van Damme, P. et al. | 2003
- 7
-
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B*Sprengers, D. / Janssen, H. L. A. / Kwekkeboom, J. / Niesters, H. G. M. / de Man, R. A. / Schalm, S. W. et al. | 2003
- 10
-
Asian Pacific Association for Study of the Liver (APASL)| 2003
- 10
-
Lower expression of CD81 B‐cell receptor in lymphoproliferative diseases associated with hepatitis C virus infectionCacoub, P. / Bourlière, M. / Hausfater, P. / Charlotte, F. / Khiri, H. / Toci, S. / Piette, J. C. / Poynard, T. / Halfon, P. et al. | 2003
- 16
-
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis CMyers, R. P. / Patel, K. / Pianko, S. / Poynard, T. / McHutchison, J. G. et al. | 2003
- 23
-
The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothersYoung, B. W. Y. / Lee, S. S. / Lim, W. L. / Yeoh, E. K. et al. | 2003
- 31
-
Adoptive transfer of donor‐derived immunity by liver transplantation: a potential avenue to prevent hepatitis B virus reinfectionDahmen, U. / Li, J. / Dirsch, O. / Gu, Y. L. / Polywka, S. / Doebel, L. / Shen, K. / Broelsch, C. E. et al. | 2003
- 37
-
Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infectionJessner, W. / Stauber, R. / Hackl, F. / Datz, C. / Watkins-Riedel, T. / Hofer, H. / Gangl, A. / Kessler, H. / Ferenci, P. et al. | 2003
- 37
-
Early viral kinetics on treatment with pegylated interferon‐α‐2a in chronic hepatitis C virus genotype 1 infection*Jessner, W. / Stauber, R. / Hackl, F. / Datz, C. / Watkins‐Riedel, T. / Hofer, H. / Gangl, A. / Kessler, H. / Ferenci, P. et al. | 2003
- 43
-
First phase hepatitis c viral kinetics in previous nonresponders patientsCotler, S. J. / Layden, J. E. / Neumann, A. U. / Jensen, D. M. et al. | 2003
- 50
-
Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cellsBirkus, G. / Gibbs, C. S. / Cihlar, T. et al. | 2003
- 55
-
The safety and tolerability of daily infergen plus ribavirin in the treatment of naive chronic hepatitis C patientsPockros, P. J. / Reindollar, R. / McHutchison, J. / Reddy, R. / Wright, T. / Boyd, D. G. / Wilkes, L. et al. | 2003
- 55
-
The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patientsPockros, P. J. / Reindollar, R. / McHutchinson, J. / Reddy, R. / Wright, T. / Boyd, D.G. / Wilkes, L.B. et al. | 2003
- 61
-
Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*Khuroo, M. S. / Kamili, S. et al. | 2003
- 70
-
Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitopePark, J.‐H. / Lee, M.‐K. / Kim, H.‐S. / Kim, K. L. / Cho, E.‐W. et al. | 2003
- 81
-
Cerebral dysfunction in chronic hepatitis C infectionForton, D. M. / Taylor‐Robinson, S. D. / Thomas, H. C. et al. | 2003
- 87
-
Mutations in the NS5A and E2‐PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirinHung, C.‐H. / Lee, C.‐M. / Lu, S.‐N. / Lee, J.‐F. / Wang, J.‐H. / Tung, H.‐D. / Chen, T.‐M. / Hu, T.‐H. / Chen, W.‐J. / Changchien, C.‐S. et al. | 2003
- 95
-
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samplesPollicino, T. / Raffa, G. / Squadrito, G. / Costantino, L. / Cacciola, I. / Brancatelli, S. / Alafaci, C. / Florio, M. G. / Raimondo, G et al. | 2003
- 103
-
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis CMyers, R. P. / Thibault, V. / Poynard, T. et al. | 2003
- 111
-
Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis CFattovich, G. / Zagni, I. / Fornaciari, G. / Minola, E. / Fabris, P. / Boccia, S. / Giusti, M. / Abbati, G. / Felder, M. / Rovere, P. et al. | 2003
- 118
-
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patientsTural, C. / Fuster, D. / Tor, J. / Ojanguren, I. / Sirera, G. / Ballesteros, À. / Lasanta, J. A. J. / Planas, R. / Rey‐Joly, C. / Clotet, B. et al. | 2003
- 126
-
Long‐term liver histology improvement in patients with chronic hepatitis C and sustained response to interferonToccaceli, F. / Laghi, V. / Capurso, L. / Koch, M. / Sereno, S. / Scuderi, M. / The Italian Hepanet Group et al. | 2003
- 134
-
Cross‐sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services’ sexually transmitted disease clinicsD'Souza, G. / Arafat, R. / Hwang, L. / Cunningham, C. / Shah, S. / Reynolds, K. et al. | 2003
- 141
-
Hepatitis B in St Petersburg, Russia (1994–1999): incidence, prevalence and force of infectionBeutels, Ph. / Shkedy, Z. / Mukomolov, S. / Aerts, M. / Shargorodskaya, E. / Plotnikova, V. / Molenberghs, G. / Van Damme, P. et al. | 2003
- 150
-
Seroprevalences of hepatitis B and C among health care workers in TurkeyOzsoy, M. F. / Oncul, O. / Cavuslu, S. / Erdemoglu, A. / Emekdas, G. / Pahsa, A. et al. | 2003
- 157
-
Who should receive hepatitis A vaccine?Arankalle, V. A. / Chadha, M. S. et al. | 2003
- 159
-
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infectionTang, T. J. / Kwekkeboom, J. / Laman, J. D. / Niesters, H. G. M. / Zondervan, P. E. / de Man, R. A. / Schalm, S. W. / Janssen, H. L. A. et al. | 2003
- 168
-
Increasing serum levels of IgM anti‐HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flaresCiccorossi, P. / Filipponi, F. / Oliveri, F. / Campani, D. / Colombatto, P. / Bonino, F. / Campa, M. / Maltinti, G. / Mosca, F. / Brunetto, M. R. et al. | 2003
- 174
-
Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot studyWeegink, C. J. / Sentjens, R. E. / Beld, M. G. / Dijkgraaf, M. G. W. / Reesink, H. W. et al. | 2003
- 174
-
Chronic hepatitis C patients with a post‐treatment virological relapse re‐treated with an induction dose of 18 MU interferon‐α in combination with ribavirin and amantadine: a two‐arm randomized pilot studyWeegink, C. J. / Sentjens, R. E. / Beld, M. G. / Dijkgraaf, M. G. W. / Reesink, H. W. et al. | 2003
- 183
-
Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stageSerra, M. A. / Rodríguez, F. / Del Olmo, J. A. / Escudero, A. / Rodrigo, J. M. et al. | 2003
- 189
-
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1Tassopoulos, N. C / Tsantoulas, D. / Raptopoulou, M. / Vassiliadis, T. / Kanatakis, S. / Paraskevas, E. / Vafiadis, I. / Avgerinos, A. / Tzathas, C. / Manolakopoulos, S. et al. | 2003
- 197
-
Reinforced interferon alpha‐2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialPoynard, T. / Marcellin, P. / Bissery, A. / Myers, R. P. / Moussalli, J. / Degos, F. / Dhumeaux, D. / Riachi, G. / Bronowicki, J. P. / Brissot, P. et al. | 2003
- 205
-
High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapyVrolijk, J. M. / Bekkering, F. C. / Brouwer, J. T. / Hansen, B. E. / Schalm, S. W. et al. | 2003
- 210
-
Interferon alpha in the treatment of chronic hepatitis C in children: a metanalysisDi Ciommo, V. / Russo, P. / Rava, L. / Caprino, L. et al. | 2003
- 210
-
Interferon α in the treatment of chronic hepatitis C in children: a metanalysisCiommo, V. Di / Russo, P. / Ravà, L. / Caprino, L. et al. | 2003
- 215
-
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder‐relapser hepatitis C patients: a prospective multicentre randomized controlled studyPortal, I. / Bourlière, M. / Halfon, P. / De Lédinghen, V. / Couzigou, P. / Bernard, P. H. / Blanc, F. / Caroli‐Bosc, F. / Arpurt, J. P. / Vetter, D. et al. | 2003
- 224
-
Aetiology and prognostic factors in acute liver failure in IndiaKhuroo, M. S. / Kamili, S. et al. | 2003
- 232
-
Alarming prevalence of hepatitis‐B infection among the Jarawas – a primitive Negrito tribe of Andaman and Nicobar Islands, IndiaMurhekar, M. V. / Murhekar, K. M. / Sehgal, S. C. et al. | 2003
- 234
-
Evidence of patient‐to‐patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoulesTallis, G. F. / Ryan, G. M. / Lambert, S. B. / Bowden, D. S. / McCaw, R. / Birch, C. J. / Moloney, M. / Carnie, J. A. / Locarnini, S. A. / Rouch, G. J. et al. | 2003
- 241
-
Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus‐related chronic hepatitis and its implication in hepatocellular carcinogenesisMiyaji, K. / Nakagawa, Y. / Matsumoto, K. / Yoshida, H. / Morikawa, H. / Hongou, Y. / Arisaka, Y. / Kojima, H. / Inoue, T. / Hirata, I. et al. | 2003
- 249
-
Dual effects of hepatitis C virus Core protein on the transcription of cyclin‐dependent kinase inhibitor p21 geneKwun, H. J. / Jang, K. L. et al. | 2003
- 256
-
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudineBozdayi̇, A. M. / Uzunalimoğlu, Ö. / Türkyi̇lmaz, A. R. / Aslan, N. / Sezgin, O. / Sahin, T. / Bozdayi̇, G. / Çi̇nar, K. / Pai, S. B. / Pai, R. et al. | 2003
- 266
-
Liver p53 expression in patients with HCV‐related chronic hepatitisLoguercio, C. / Cuomo, A. / Tuccillo, C. / Gazzerro, P. / Cioffi, M. / Molinari, A. M. / Del Vecchio Blanco, C. et al. | 2003
- 271
-
Twice‐weekly administration of peginterferon‐α‐2b improves viral kinetics in patients with chronic hepatitis C genotype 1Formann, E. / Jessner, W. / Bennett, L. / Ferenci, P. et al. | 2003
- 271
-
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1Formann, E. / Jessner, W. / Bennett, L. / Ferenci, P. et al. | 2003
- 277
-
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen‐negative chronic hepatitis B patients in TaiwanHuang, Y.‐H. / Wu, J.‐C. / Chang, T.‐T. / Sheen, I.‐J. / Lee, P.‐C. / Huo, T.‐I. / Su, C.‐W. / Wang, Y.‐J. / Chang, F.‐Y. / Lee, S.‐D. et al. | 2003
- 285
-
Predicting progression to cirrhosis in chronic hepatitis C virus infectionFreeman, A. J. / Law, M. G. / Kaldor, J. M. / Dore, G. J. et al. | 2003
- 294
-
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infectionvan Zonneveld, M. / van Nunen, A. B. / Niesters, H. G. M. / de Man, R. A. / Schalm, S. W. / Janssen, H. L. A. et al. | 2003
- 298
-
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis BCooksley, W. G. E. / Piratvisuth, T. / Lee, S.-D. / Mahachai, V. / Chao, Y.-C. / Tanwandee, T. / Chutaputti, A. / Chang, W. Y. / Zahm, F. E. / Pluck, N. et al. | 2003
- 298
-
Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis BCooksley, W. G. E. / Piratvisuth, T. / Lee, S.‐D. / Mahachai, V. / Chao, Y.‐C. / Tanwandee, T. / Chutaputti, A. / Chang, W. Yu / Zahm, F. E. / Pluck, N. et al. | 2003
- 306
-
Interferon‐α combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trialAndreone, P. / Gramenzi, A. / Cursaro, C. / Biselli, M. / Lorenzini, S. / Loggi, E. / Felline, F. / Fiorino, S. / Di Giammarino, L. / Porzio, F. et al. | 2003
- 306
-
Interferon-alpha combined with ketoprofen as treatment of naive patients with chronic hepatitis C: a randomized controlled trialAndreone, P. / Gramenzi, A. / Cursaro, C. / Biselli, M. / Lorenzini, S. / Loggi, E. / Felline, F. / Fiorino, S. / Di Giammarino, L. / Porzio, F. et al. | 2003
- 310
-
Modulation of endothelial cell inflammatory integrins and stress markers with rh‐factor VIIa in patients with advanced chronic hepatitis CVan Thiel, D. H. / Anantharaju, A. / Mindikoglu, A. L. / Shah, N. / Leone, N. / Bejna, J. / Tarasuk, G. / Todo, A. / Mobarhan, S. / George, M. et al. | 2003
- 318
-
Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients’ response to therapyMaynard, M. / Pradat, P. / Berthillon, P. / Picchio, G. / Voirin, N. / Martinot, M. / Marcellin, P. / Trepo, C. et al. | 2003
- 324
-
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core‐related antigen; a marker distinct from viral DNA for monitoring lamivudine treatmentRokuhara, A. / Tanaka, E. / Matsumoto, A. / Kimura, T. / Yamaura, T. / Orii, K. / Sun, X. / Yagi, S. / Maki, N. / Kiyosawa, K. et al. | 2003
- 331
-
A rapid immunochromatographic assay for hepatitis B virus screeningLau, D. T.‐Y. / Ma, H. / Lemon, S. M. / Doo, E. / Ghany, M. G. / Miskovsky, E. / Woods, G. L. / Park, Y. / Hoofnagle, J. H. et al. | 2003
- 335
-
Apoptosis in hepatitis CKountouras, J. / Zavos, C. / Chatzopoulos, D. et al. | 2003
- 343
-
Hepatitis B vaccination and multiple sclerosis: evidence from a systematic reviewDemicheli, V. / Rivetti, A. / Pietrantonj, C. Di / Clements, C. J. / Jefferson, T. et al. | 2003
- 345
-
Improved detection of hepatocyte proliferation using antibody to the pre‐replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infectionFreeman, A. / Hamid, S. / Morris, L. / Vowler, S. / Rushbrook, S. / Wight, D. G. D. / Coleman, N. / Alexander, G. J. M. et al. | 2003
- 351
-
Slow viral dynamics of hepatitis C virus genotype 4Halfon, P. / Neumann, A. U. / Bourlière, M. / Rieu, A. / Chadapaud, S. / Khiri, H. / Ouzan, D. / Cacoub, P. et al. | 2003
- 354
-
Comparison of 125I-interferon-a binding to peripheral blood cells from African-Americans and Caucasians with hepatitis CKimball, P. / Verbeke, S. / Shiffman, M. et al. | 2003
- 354
-
Comparison of 125I‐interferon‐α binding to peripheral blood cells from African–Americans and Caucasians with hepatitis CKimball, P. / Verbeke, S. / Shiffman, M. et al. | 2003
- 360
-
Plasma and hepatic tissue levels of thrombomodulin, tissue factor, NFκB and nitric oxide in responders and nonresponders to IFNα therapyGeorge, M. / Baluch, M. / Van Thiel, D. H. et al. | 2003
- 360
-
Plasma and hepatic tissue levels of thrombomodulin, tissue factor, NFkB and nitric oxide in responders and nonresponders to IFNa therapyGeorge, M. / Baluch, M. / Van Thiel, D. H. et al. | 2003
- 367
-
Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patientsGandhe, S. S. / Chadha, M. S. / Walimbe, A. M. / Arankalle, V. A. et al. | 2003
- 383
-
A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naive patients with chronic hepatitis CTassopoulos, N. C. / Ketikoglou, I. / Tsantoulas, D. / Raptopoulou, M. / Hatzis, G. / Vafiadis, I. / Sidiropoulos, L. / Kanatakis, S. / Anagnostopoulos, G. / Sypsa, V. et al. | 2003
- 383
-
A randomized trial to assess the efficacy of interferon‐alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis CTassopoulos, N. C. / Ketikoglou, I. / Tsantoulas, D. / Raptopoulou, M. / Hatzis, G. / Vafiadis, I. / Sidiropoulos, L. / Kanatakis, S. / Anagnostopoulos, G. / Sypsa, V. et al. | 2003
- 390
-
Mycophenolate mofetil in the treatment of autoimmune HCV‐associated haematological disorders showing steroid resistance or dependenceIerardi, E. / Rendina, M. / Francavilla, R. / Barone, M. / Castellaneta, A. / Panella, C. / Francavilla, A. / Cuomo, R. et al. | 2003
- 394
-
Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in ItalyQuaglio, G. L. / Lugoboni, F. / Pajusco, B. / Sarti, M. / Talamini, G. / Mezzelani, P. / Des Jarlais, D. C. / GICS et al. | 2003
- 401
-
Intracerebral haemorrhage and hepatitis C treatmentFerencz, S. / Batey, R. et al. | 2003
- 405
-
Structure‐based design of hepatitis C virus inhibitorsSmith, R. M. / Wu, G. Y. et al. | 2003
- 413
-
Dynamics of hepatitis C virus quasispecies turnover during interferon-a treatmentWagner, M. / Lee, J. H. / Ruster, B. / Kronenberger, B. / Sarrazin, C. / Roth, W. K. / Zeuzem, S. et al. | 2003
- 413
-
Dynamics of hepatitis C virus quasispecies turnover during interferon‐α treatmentvon Wagner, M. / Lee, J.‐H. / Rüster, B. / Kronenberger, B. / Sarrazin, C. / Roth, W. K. / Zeuzem, S. et al. | 2003
- 423
-
A prospective study of blood alpha‐fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosisIavarone, M. / Lampertico, P. / Ronchi, G. / Del Ninno, E. / Zanella, A. / Colombo, M. et al. | 2003
- 427
-
Hepatitis C virus proteins do not directly trigger fibrogenic events in cultured human liver myofibroblastsTan, K. / Guibert, C. / Neaud, V. / Rosenbaum, J. et al. | 2003
- 433
-
Effects of hepatitis A vaccination on atherogenesis in a murine modelBurnett, M. S. / Zhu, J. / Miller, J. M. / Epstein, S. E. et al. | 2003
- 437
-
Comparative study of the efficacy of an induction dose of interferon-a2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis CPerez, R. / Jimenez, M. / Crespo, J. / Diago, M. / Enriquez, J. / Vaquero, P. / Sola, R. / Olcoz, J. L. / Romero, M. / Salmeron, J. et al. | 2003
- 437
-
Comparative study of the efficacy of an induction dose of interferon‐α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis CPérez, R. / Jiménez, M. / Crespo, J. / Diago, M. / Enríquez, J. / Vaquero, P. / Solá, R. / Olcoz, J. L. / Romero, M. / Salmerón, J. et al. | 2003
- 446
-
A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infectionSomani, S. K. / Aggarwal, R. / Naik, S. R. / Srivastava, S. / Naik, S. et al. | 2003
- 450
-
Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observationsRaptis, I. / Koskinas, J. / Emmanouil, T. / Hadziyannis, S. et al. | 2003
- 455
-
Occult hepatitis C virus infection in type II mixed cryoglobulinaemiaCasato, M. / Lilli, D. / Donato, G. / Granata, M. / Conti, V. / Del Giudice, G. / Rivanera, D. / Scagnolari, C. / Antonelli, G. / Fiorilli, M. et al. | 2003
- 460
-
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *Van Vlierberghe, H. / Leroux‐Roels, G. / Adler, M. / Bourgeois, N. / Nevens, F. / Horsmans, Y. / Brouwer, J. / Colle, I. / Delwaide, J. / Brenard, R. et al. | 2003
- 467
-
Vogt‐Koyanagi‐Harada disease associated with interferon alpha‐2b/ribavirin combination therapySylvestre, D. L. / Disston, A. R. / Bui, D. P. et al. | 2003
- 471
-
Author index| 2003
- 477
-
Subject index| 2003